Legend Biotech (LEGN) Amortization of Goodwill (2024 - 2025)

Legend Biotech (LEGN) reported Amortization of Goodwill of -$970000.0 for Q1 2025, down 21830.82% quarter-over-quarter from -$4423.0 in Q4 2024.

Legend Biotech (LEGN) Amortization of Goodwill (2024 - 2025) Analysis & Trends

Legend Biotech has reported Amortization of Goodwill for 2 years, with the latest figure at -$970000.0 in Q1 2025.

For the quarter ending Q1 2025, Amortization of Goodwill changed N/A year-over-year to -$970000.0; the trailing twelve-month figure through Sep 2025 stood at -$974423.0 (changed N/A YoY), and the FY2024 full-year result was -$4423.0, changed N/A from the prior year.
Amortization of Goodwill for Q1 2025 stood at -$970000.0, down from -$4423.0 in the prior quarter.
The five-year high for Amortization of Goodwill was -$4423.0 in Q4 2024, with the low at -$970000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Regeneron Pharmaceuticals	63.43 Bn	54.67 Bn	3.31 Bn

Download Data